Estrogen positive breast cancer recurrence during tamoxifen therapy: whole tissue tumor
Summary:
Expression profiling of estrogen positive primary breast cancer tumors from 60 patients. Patients subsequently treated with tamoxifen for 5 years, and tumors classified according to whether cancer recurred. Results identify gene markers of disease-free survival that include HOXB13 and IL17BR.
GPL1223:
Arcturus 22k human oligonucleotide microarray
Citation:
Ma XJ, Wang Z, Ryan PD, Isakoff SJ et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004 Jun;5(6):607-16. PMID: 15193263
